Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Franchini

Showing results (161-170 of 749) with videos related to

Pageof 75
Sort By:
European Journal of Internal Medicine|October 26, 2012
New anticoagulants for treatment of venous thromboembolismMassimo Franchini, Pier Mannuccio Mannucci
British Journal of Haematology|February 26, 2013
Von Willebrand disease-associated angiodysplasia: a few answers, still many questionsMassimo Franchini, Pier Mannuccio Mannucci
Thrombosis and Haemostasis|September 7, 2013
Acquired haemophilia A: a 2013 updateMassimo Franchini, Pier Mannuccio Mannucci
Seminars in Thrombosis and Hemostasis|June 10, 2014
The history of hemophiliaMassimo Franchini, Pier Mannuccio Mannucci
Seminars in Thrombosis and Hemostasis|December 17, 2008
Von Willebrand factor: another janus-faced hemostasis proteinMassimo Franchini, Pier Mannuccio Mannucci
Expert Review of Hematology|September 19, 2014
The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolismPier Mannuccio Mannucci, Massimo Franchini
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
ABO blood group and neurodegenerative disorders: more than a casual associationMassimo Franchini, Giancarlo M Liumbruno
Expert Opinion on Drug Safety|July 2, 2016
The safety of pharmacologic options for the treatment of persons with hemophiliaMassimo Franchini, Pier Mannuccio Mannucci
Current Opinion in Hematology|August 28, 2014
Adjunct agents for bleedingMassimo Franchini, Pier Mannuccio Mannucci
Journal of Thrombosis and Thrombolysis|November 16, 2013
Hemostasis, cancer, and ABO blood group: the most recent evidence of associationGiancarlo Maria Liumbruno, Massimo Franchini
Pageof 75

Showing results (161-170 of 749) with videos related to

Sort By:
Pageof 75
European Journal of Internal Medicine|October 26, 2012
New anticoagulants for treatment of venous thromboembolismMassimo Franchini, Pier Mannuccio Mannucci
British Journal of Haematology|February 26, 2013
Von Willebrand disease-associated angiodysplasia: a few answers, still many questionsMassimo Franchini, Pier Mannuccio Mannucci
Thrombosis and Haemostasis|September 7, 2013
Acquired haemophilia A: a 2013 updateMassimo Franchini, Pier Mannuccio Mannucci
Seminars in Thrombosis and Hemostasis|June 10, 2014
The history of hemophiliaMassimo Franchini, Pier Mannuccio Mannucci
Seminars in Thrombosis and Hemostasis|December 17, 2008
Von Willebrand factor: another janus-faced hemostasis proteinMassimo Franchini, Pier Mannuccio Mannucci
Expert Review of Hematology|September 19, 2014
The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolismPier Mannuccio Mannucci, Massimo Franchini
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
ABO blood group and neurodegenerative disorders: more than a casual associationMassimo Franchini, Giancarlo M Liumbruno
Expert Opinion on Drug Safety|July 2, 2016
The safety of pharmacologic options for the treatment of persons with hemophiliaMassimo Franchini, Pier Mannuccio Mannucci
Current Opinion in Hematology|August 28, 2014
Adjunct agents for bleedingMassimo Franchini, Pier Mannuccio Mannucci
Journal of Thrombosis and Thrombolysis|November 16, 2013
Hemostasis, cancer, and ABO blood group: the most recent evidence of associationGiancarlo Maria Liumbruno, Massimo Franchini
Pageof 75